Skip to main content
Top

Current Cardiology Reports

Issue 1/2012

Content (14 Articles)

Myocardial Edema Imaging by Cardiovascular Magnetic Resonance: Current Status and Future Potential

  • Cardiac PET, CT, and MRI (S Achenbach, Section Editor)

Iacopo Carbone, Matthias G. Friedrich

The Prognostic Significance of Coronary CT Angiography

  • Cardiac PET, CT, and MRI (S Achenbach, Section Editor)

Kevin M. Woods, Collin Fischer, Michael K. Cheezum, Edward A. Hulten, Binh Nguyen, Todd C. Villines

Low-Dose Cardiovascular Computed Tomography: Where are the Limits?

  • Cardiac PET, CT, and MRI (S Achenbach, Section Editor)

Paul Schoenhagen, Carla M. Thompson, Sandra S. Halliburton

Cardiac PET, CT, and MR: What Are the Advantages of Hybrid Imaging?

  • Cardiac PET, CT, and MRI (S Achenbach, Section Editor)

Antti Saraste, Juhani Knuuti

Promises of PAR-1 Inhibition in Acute Coronary Syndrome

  • New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

Sergio Leonardi, Pierluigi Tricoci, Kenneth W. Mahaffey

Promise of Factor Xa Inhibition in Acute Coronary Syndromes

  • New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

Leong Lee, Derek Chew

Clopidogrel and PPI Interaction: Clinically Relevant or Not?

  • New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

Robert W. Harrison, Kenneth W. Mahaffey

Impact of FDA Guidance for Developing Diabetes Drugs on Trial Design: From Policy to Practice

  • New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

M. Angelyn Bethel, Harald Sourij

Promise of Factor Xa Inhibition in Atrial Fibrillation

  • New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

Sana M. Al-Khatib, John H. Alexander, Renato D. Lopes, Kenneth W. Mahaffey, Manesh R. Patel, Christopher B. Granger

Does Aggressive Glycemic Control Benefit Macrovascular and Microvascular Disease in Type 2 Diabetes?: Insights from ACCORD, ADVANCE, and VADT

  • Diabetes and Cardiovascular Disease (ND Wong, Section Editor)

Toni Terry, Kalyani Raravikar, Nalurporn Chokrungvaranon, Peter D. Reaven

Tight Blood Pressure Control in Diabetes: Evidence-Based Review of Treatment Targets in Patients with Diabetes

  • Diabetes and Cardiovascular Disease (ND Wong, Section Editor)

Gianpaolo Reboldi, Giorgio Gentile, Valeria Maria Manfreda, Fabio Angeli, Paolo Verdecchia

Provider and Systems Factors in Diabetes Quality of Care

  • Diabetes and Cardiovascular Disease (ND Wong, Section Editor)

Kimia Ghaznavi, Shaista Malik

Projected and Observed Diabetes Epidemics in China and Beyond

  • Diabetes and Cardiovascular Disease (ND Wong, Section Editor)

Dong Zhao, Fan Zhao, Yan Li, Zheng Zheng

Do Persons with Diabetes Benefit from Combination Statin and Fibrate Therapy?

  • Diabetes and Cardiovascular Disease (ND Wong, Section Editor)

Paul D. Rosenblit

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME